Statin adverse event?
This article was originally published in The Tan Sheet
Executive Summary
Bayer withdraws Rx cholesterol-lowering statin Baycol (cerivastatin) due to prevalence of rhabdomyolysis, including 31 fatal cases, at low doses, FDA says Aug. 8. Agency suggests Baycol users talk to doctors about switching to alternative statins, including Merck's Mevacor and BMS' Pravachol, both of which were subject to OTC switch consideration last summer (1"The Tan Sheet" July 17, 2000, pp. 3-6). Public Citizen plans to petition FDA to include "black box" warning on all Rx statins informing patients of serious adverse event risks, group says